GCP/GLP/GMP : Comparison And Understanding of the FDA's 3 Major Regulations

Various firms are subject to various relevant and applicable federal regulations including, but not limited to, Good Laboratory Practice (GLP), Current Good Manufacturing Practice (cGMP), and Good Clinical Practice (GCP). It is important for the industry to accurately understand the requirements under Good Laboratory Practice (GLP), Good Clinical Practice (GCP) and current Good Manufacturing Practice (cGMP). This seminar is intended to help industry get better familiar with the GLP, GCP and cGMP requirements from regulatory, practical and compliance perspectives.

Why You Should Attend:

These are the 3 major regulations FDA uses to regulate the Pharmaceutical/Medical Device industries in the USA. This web presentation presents an overview of FDA’s 3 major regulations – Good Clinical Practices (GCP), Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). Although varying slightly in different regions of the world these 3 regulations have the same basic elements and interpretations globally. Learn the requirements for each regulation, how they fit into the development process and how they are same and how they differ. Learn when to use each regulation and how FDA interprets the regulation. The speaker will walk you through regulatory and compliance requirements governing GLP, cGMP and GCP. 

Areas Covered in the Session :

• FDA Guidance and Standards
• Major Misconception
• Overview of each regulation – GCP, GLP, GMP
• How each regulation is the same
• How each regulation differs
• FDA’s interpretation of each regulation
• Regulations and Requirements for each

Who Should Attend:

• Quality Assurance Departments
• Quality Control Departments
• Research and Development Departments
• Regulatory Affairs Departments
• Manufacturing Departments
• Engineering Departments
• Operations Departments
• Production Departments
• Validation Departments
• Marketing Departments
• Documentation Departments

Course Director: JOHN E. LINCOLN ‎

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 36 years experience in U.S. FDA-regulated industries, 22 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files, CAPA systems and analysis. He’s held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. He writes a recurring column for the Journal of Validation Technology. John is a graduate of UCLA.